Publications 2000

A Meta-Analysis of Low Molecular Weight Heparins (LMWHs) to Unfractionated Heparin in the Treatment of Venous Thromboembolism: Examining Some Unanswered Questions. Arch Int Med 2000;160:181-8. Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM , Cheah G.
Building Uncertainty into Cost-Effectiveness Rankings: Portfolio Risk-Return Trade-Offs and Implications for Decision Rules Medical Care, 2000;38(5)460-468. O'Brien BJ, Sculpher MJ.
Canadian Implantable Defibrillator Study (CIDS): A Randomized Trial of the Implantable Cardioverter Defibrillator Against Amiodarone. Circulation. 2000;101:1297-1302. Stuart J. Connolly, Michael Gent, Robin S. Roberts, et.al. (view article)
Development, Dissemination, Implementation and Evaluation of a Clinical Pathway for Oxygen Therapy Canadian Medical Association Journal, 2000;162(1):29-33. Wong C, Visram F, Cook D, Griffith L, Randall J, O'Brien B, Higgins D.
Health Utilities Index Mark 3: Evidence of construct validity for stroke and arthritis in a population health survey” Forthcoming in Medical Care March 2000. Grootendorst P, Feeny D, Furlong W.
Income Effects of Reduced Health and Health Effects of Reduced Income: Implications for Health State Valuation. Medical Decision Making 2000;20:207-215. Sculpher MJ, O'Brien BJ.
Meta-analysis of Benzodiazepine Use in the Treatment of Insomnia. CMAJ 2000;162:225-233. Holbrook AM, Crowther R, Lotter A, Cheng C, King D.
Systematic Implementation of an Advanced Directive Program in Nursing Homes: a Randomized Controlled Trial. JAMA 2000;283(11):1437-1444. Molloy G, Guyatt G, Jubelius R, Goeree R, O'Brien B, Bedard M, Willan A, Watson J, et al.
Test and Treat Strategies for Helicobacter Pylori in Uninvestigated Dyspepsia: a Canadian Economic Analysis. Canadian Journal of Gasteroenterology, 2000;14(5):379-388. Marshall JK, Armstrong D, O'Brien BJ.
The Diagnosis and Management of Insomnia in Clinical Practice: a Practical Evidence-Based Approach. CMAJ 2000;162:216-20. Holbrook AM, Crowther R, Lotter A, Cheng C, King D.
Use of Venous Thromboembolism Prophylaxis Following Total Hip or Knee Arthroplasty: A survey of Canadian Orthopedic Surgeons. Canadian Journal of Surgery, 1999;42:457-61. Gross M, Anderson DR, Nagpal S, O'Brien B.
Will the Use of Low-Molecular-Weight Heparin (enoxaparin) in Patients with Acute Coronary Syndrome Save Costs in Canada? Americal Heart Journal, 2000;139:423-9. Bernie J. O'Brien, Andrew Willan, Gordon Blackhouse, et.al.(view article)
Ontario drug therapy guidelines for chronic heart failure in primary care. Levine M (Chair and lead author) and the Consensus panel. Queen's Printer of Ontario , Toronto , 2000. Click here for a PDF version
Ontario drug therapy guidelines for stable ischemic heart disease in primary care. Levine M (Chair and lead author) and the Consensus Panel. Queen's Printer of Ontario , Toronto , 2000. Click here for a PDF version
Ontario guidelines for the pharmacotherapeutic management of diabetes mellitus. Levine M (Chair and lead author) and the Consensus Panel. Queen's Printer of Ontario , Toronto , 2000. Click here for a PDF version
Ontario guidelines for the prevention and treatment of osteoporosis. Levine M (Chair and lead author) and Consensus Panel. Queen's Printer of Ontario , Toronto , 2000. Click here for a PDF version
Medical treatment guidelines for peptic ulcer disease and gastroesophageal reflux disease. Holbrook AM, for the Ontario G.I. Therapy Panel. Queen’s Printer of Ontario, Toronto , 2000 Click here for a PDF version
Medical treatment guidelines for the treatment of osteoarthritis, rheumatoid arthritis and acute musculoskeletal injury. Holbrook AM, for the Ontario Musculoskeletal Therapy Review Panel. Queen’s Printer Ontario, Toronto 2000. Click here for a PDF version
Ontario guidelines for the management of anxiety disorders in primary care. Bradwejn J, and Evans M. for the Ontario Anxiety Review Panel. Queen’s Printer of Ontario, Toronto 2000. Click here for a PDF version